Search research articles
Contact Us
Filters
Showing results (41-50 of 96) with videos related to
Page
of 10
Sort By:
Statistics in Medicine
|
May 15, 2024
Design and sample size determination for multiple-dose randomized phase II trials for dose optimization
Peng Yang, Daniel Li, Ruitao Lin, et al.
JCO Precision Oncology
|
December 7, 2020
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies
Ruitao Lin, Yanhong Zhou, Fangrong Yan, et al.
Statistics in Medicine
|
June 10, 2024
REDOMA: Bayesian random-effects dose-optimization meta-analysis using spike-and-slab priors
Cheng-Han Yang, Evan Kwiatkowski, J Jack Lee, et al.
Statistics in Medicine
|
April 11, 2025
A Generalized Phase I/II Dose Optimization Trial Design With Multi-Categorical and Multi-Graded Outcomes
Yichen Yan, Ruitao Lin, Tianyu Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2018
Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials
Ying Yuan, Ruitao Lin, Daniel Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2026
Generalised pairwise comparisons in dose-optimisation oncology trials: beyond safety to multi-outcome dose selection
Emily Alger, Ruitao Lin, J Jack Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Practical Considerations for Using the TITE-BOIN Design to Handle Late-onset Toxicity or Fast Accrual in Phase I Trials
Kai Chen, Ting-Yu Chen, Yiming Zhang, et al.
Statistics in Medicine
|
December 3, 2025
Bayesian Integrated Learning of Longitudinal Dose-Response Relationships via Decentralized Clinical Trials
Jingyi Zhang, Tuo Wang, Yongming Qu, et al.
JCO Precision Oncology
|
August 29, 2024
Pharmacodynamic Activity of [<sup>18</sup>F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With <i>BRCA1/2</i>-Mutated Breast Cancer Receiving Talazoparib
Lilie L Lin, Franklin Wong, Ruitao Lin, et al.
JCO Clinical Cancer Informatics
|
January 13, 2021
BOIN Suite: A Software Platform to Design and Implement Novel Early-Phase Clinical Trials
Yanhong Zhou, Ruitao Lin, Ying-Wei Kuo, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 96) with videos related to
Sort By:
Page
of 10
Statistics in Medicine
|
May 15, 2024
Design and sample size determination for multiple-dose randomized phase II trials for dose optimization
Peng Yang, Daniel Li, Ruitao Lin, et al.
JCO Precision Oncology
|
December 7, 2020
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies
Ruitao Lin, Yanhong Zhou, Fangrong Yan, et al.
Statistics in Medicine
|
June 10, 2024
REDOMA: Bayesian random-effects dose-optimization meta-analysis using spike-and-slab priors
Cheng-Han Yang, Evan Kwiatkowski, J Jack Lee, et al.
Statistics in Medicine
|
April 11, 2025
A Generalized Phase I/II Dose Optimization Trial Design With Multi-Categorical and Multi-Graded Outcomes
Yichen Yan, Ruitao Lin, Tianyu Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2018
Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials
Ying Yuan, Ruitao Lin, Daniel Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2026
Generalised pairwise comparisons in dose-optimisation oncology trials: beyond safety to multi-outcome dose selection
Emily Alger, Ruitao Lin, J Jack Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Practical Considerations for Using the TITE-BOIN Design to Handle Late-onset Toxicity or Fast Accrual in Phase I Trials
Kai Chen, Ting-Yu Chen, Yiming Zhang, et al.
Statistics in Medicine
|
December 3, 2025
Bayesian Integrated Learning of Longitudinal Dose-Response Relationships via Decentralized Clinical Trials
Jingyi Zhang, Tuo Wang, Yongming Qu, et al.
JCO Precision Oncology
|
August 29, 2024
Pharmacodynamic Activity of [<sup>18</sup>F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With <i>BRCA1/2</i>-Mutated Breast Cancer Receiving Talazoparib
Lilie L Lin, Franklin Wong, Ruitao Lin, et al.
JCO Clinical Cancer Informatics
|
January 13, 2021
BOIN Suite: A Software Platform to Design and Implement Novel Early-Phase Clinical Trials
Yanhong Zhou, Ruitao Lin, Ying-Wei Kuo, et al.
Page
of 10